Wolters Kluwer Agrees to Buy Clinical AI Company AgileMD

What happened

On November 13, 2026, Wolters Kluwer Health announced it had reached an agreement to acquire AgileMD, a clinical AI company based in San Francisco, for up to $100 million. The deal includes a $40 million upfront payment and additional payments based on future performance. AgileMD’s 23 employees, including its co-founders, are expected to join Wolters Kluwer Health. The transaction is expected to close in the first quarter of 2027, pending regulatory approvals and other standard conditions.

Key details

• AgileMD serves over 400 hospitals and 150,000 clinical users.
• The company’s eCART product is FDA-cleared and uses AI to detect patient deterioration in real time.
• AgileMD’s Pathways product integrates local clinical guidelines into electronic health record workflows.
• The acquisition is projected to bring AgileMD to $7 million in annual recurring revenue by the end of 2026.
• Wolters Kluwer plans to combine AgileMD’s tools with its UpToDate Expert AI platform, which is used by more than 2,700 U.S. hospitals and health systems.

Why it matters

Hospitals and clinicians using Wolters Kluwer’s platforms will gain access to new AI-powered tools for monitoring patient risk and integrating clinical guidelines directly into their workflows. This could help care teams respond more quickly to patient deterioration and streamline decision-making processes. For Wolters Kluwer, the acquisition is expected to expand its digital health offerings and connect its existing customer base with AgileMD’s technology, with a financial return target set for three to five years.